CytomX Therapeutics, Inc. (CTMX)
4.39
+0.15
(+3.54%)
USD |
NASDAQ |
Apr 10, 16:00
4.39
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Total Liabilities (Quarterly) : 53.49M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| Rigel Pharmaceuticals, Inc. | 169.14M |
| REGENXBIO, Inc. | 350.30M |
| Ovid Therapeutics, Inc. | 20.27M |
| Olema Pharmaceuticals, Inc. | 198.76M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 152.50M |
| Shareholders Equity (Quarterly) | 99.01M |
| Debt to Equity Ratio | 0.0428 |
| Current Ratio | 3.087 |
| Net Debt Paydown Yield | 0.18% |